Product Information
LEVETIRACETAM 750 MG TABLET is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.1105 per EA under NDC 50228047212. Its NADAC has been published 184 times since Feb 15, 2023.
FDA first approved this application on Jun 11, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
750 mg/1
Manufacturer
ScieGen Pharmaceuticals, Inc.NDC
50228047212
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA215069FDA Approved
6/11/2021
TE Code
AB
On Market Since
6/11/2021
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 750 MG TABLET has been published 184 times since Feb 15, 2023, and over the history we have for it it has declined 23.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1105 per EA |
|---|---|
| All-time high | $0.1572 (Jul 12, 2023) |
| All-time low | $0.0954 (Nov 20, 2024) |
| 52-week high | $0.1191 |
| 52-week low | $0.1105 |
| Median price | $0.1204 |
| Average price | $0.1244 |
| Largest weekly change | -24.3% (Nov 20, 2024) |
| Weeks tracked | 184 |
| Tracking since | Feb 15, 2023 |
Generic Alternatives
The matcher finds 20 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 750 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 750 MG TABLET, manufactured by ScieGen Pharmaceuticals, Inc., is $0.1105 per EA (NDC 50228047212), effective Aug 19, 2026.
How has the price of LEVETIRACETAM 750 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 750 MG TABLET has declined 23.3%. It has been tracked across 184 weekly CMS publications since Feb 15, 2023.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 750 MG TABLET?
Since Feb 15, 2023, the NADAC for LEVETIRACETAM 750 MG TABLET has ranged from a low of $0.0954 (Nov 20, 2024) to a high of $0.1572 (Jul 12, 2023), with a median of $0.1204 per EA.
Are there cheaper alternatives to LEVETIRACETAM 750 MG TABLET?
Yes. 20 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 750 MG TABLET, is $0.1056 per EA — about 4% below LEVETIRACETAM 750 MG TABLET.
Who manufactures LEVETIRACETAM 750 MG TABLET?
LEVETIRACETAM 750 MG TABLET (NDC 50228047212) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.